Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: An 8-year follow-up split-mouth study

Journal of Periodontology

Volumn 77, Issue 11, 2006, Pages 1879-1886

  Sculean, Anton ^a   Schwarz, Frank ^b   Miliauskaite, Asta ^c   Kiss, Alice ^c   Arweiler, Nicole ^d   Becker, Jürgen ^b   Brecx, Michel ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Clinical study; Enamel matrix proteins; Guided tissue regeneration; Membranes

Indexed keywords

AMOXICILLIN; EMDOGAIN; ENAMEL PROTEIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA; HUMAN; INTERMETHOD COMPARISON; MALE; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTIUM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TISSUE REGENERATION; TOOTH PLAQUE; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ADULT; ALVEOLAR BONE LOSS; BONE REGENERATION; DENTAL ENAMEL PROTEINS; DENTAL PLAQUE INDEX; FEMALE; FOLLOW-UP STUDIES; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PROSPECTIVE STUDIES;

EID: 33751260524     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.060002     Document Type: Article

References (64)

1. Caton JG, Greenstein GG. Factors related to periodontal regeneration. Periodontol 2000 1993;1:9-15.
2. Bowers GG, Chadroff B, Carnevale R, et al. Histologic evaluation of new human attachment apparatus formation in humans. Part 1. J Periodontol 1989;60:664-674.
3. Brunsvold MA, Mellonig JT. Bone grafts and periodontal regeneration. Periodontol 2000 1993;1: 80-91.
4. Lowenguth RA, Blieden TM. Periodontal regeneration: Root surface demineralization. Periodontol 2000 1993; 1:54-68.
5. Karring T, Nyman S, Gottlow J, Laurell L. Development of the biological concept of guided tissue regeneration - Animal and human studies. Periodontol 2000 1993;1:26-35.
6. Lynch SE, Williams RC, Poison AM. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989;16:545-548.
7. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24: 658-668.
8. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-188.
9. Okubo K, Kobayashi M, Takiguchi T, et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003; 38:1-9.
10. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 2001;36:367-376.
11. Kawase T, Okuda K, Yoshie H, Burns DM. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 2002;37:255-262.
12. Suzuki S, Nagano T, Yamakoshi Y, et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-β. J Dent Res 2005;84:510-514.
13. Takayama T, Suzuki N, Narukawa M, Tokunaga T, Otsuka K, Ito K. Enamel matrix derivative stimulates core binding factor alpha1/Runt-related transcription factor-2 expression via activation of Smad in C2C12 cells. J Periodontol 2005;76:244-249.
14. Nyman S, Lindhe J, Karring T, Rylander H. New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 1982;9: 290-296.
15. Gottlow J, Nyman S, Lindhe J, Karring T, Wennström J. New attachment formation in the human periodontium by guided tissue regeneration. Case reports. J Clin Periodontol 1986;13:604-616.
16. Sculean A, Donos N, Chiantella GC, Windisch P, Reich E, Brecx M. Treatment of intrabony defects with bioabsorbable membranes. A clinical and histologic study. Int J Periodontics Restorative Dent 1999;19: 501-509.
17. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:8-19.
18. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
19. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
20. Yukna RA, Mellonig J. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
21. Sculean A, Chiantella GC, Windisch P, Donos N. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 2000;20:374-381.
22. Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 2005;40:158-167.
23. Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G. Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: A human case report. Int J Periodontics Restorative Dent 2005;25:283-294.
24. Cortellini P, Pini Prato G, Tonetti MS. Periodontal regeneration of human intrabony defects with bioresorbable membranes. A controlled clinical trial. J Periodontol 1996;67:217-223.
25. Heijl L, Heden G, Svardström G, Östgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24:705-714.
26. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999; 26:833-840.
27. Okuda K, Momose M, Miyazaki A, et al. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000;71:1821-1828.
28. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V. Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 2000;27: 603-610.
29. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72: 25-34.
30. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403.
31. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 2002;29:317-325.
32. Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hurzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: A controlled clinical study. J Clin Periodontol 2003;30:496-504.
33. Francetti L, Trombelli L, Lombardo G, et al. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: A 24-month multicenter study. Int J Periodontics Restorative Dent 2005;25: 461-473.
34. Rösing CK, Aass AM, Mavropoulos A, Gjermo P. Clinical and radiographic effects of enamel matrix derivative in the treatment of intrabony periodontal defects: A 12-month longitudinal placebo-controlled clinical trial in adult periodontitis patients. J Periodontol 2005;76:129-133.
35. Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study. J Periodontol 1999;70:255-262.
36. Zucchelli G, Bernardi F, Montebugnoli L, De Sanctis M. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
37. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V. Comparison of intrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane. J Clin Periodontol 2003;30:386-393.
38. Sanz M, Tonetti MS, Zabalegui I, et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: Results from a multicenter practice-based clinical trial. J Periodontol 2004;75:726-733.
39. Gottlow J, Nyman S, Karring T. Maintenance of new attachment gained through guided tissue regeneration. J Clin Periodontol 1992;19:315-317.
40. Weigel C, Brägger U, Hämmerle CHF, Mombelli A, Lang NP. Maintenance of new attachment 1 and 4 years following guided tissue regeneration (GTR). J Clin Periodontol 1995;22:661-669.
41. Cortellini P, Pini Prato GP, Tonetti MS. Long-term stability of clinical attachment following guided tissue regeneration and conventional therapy. J Clin Periodontol 1996;23:106-111.
42. Cortellini P, Stalpers G, Pini Prato G, Tonetti M. Long-term clinical outcomes of abutments treated with guided tissue regeneration. J Prosthet Dent 1999;81: 305-311.
43. De Sanctis M, Zucchelli G. Interleukin-1 gene polymorphism and long-term stability following guided tissue regeneration therapy. J Periodontol 2000;71: 606-613.
44. Sculean A, Donos N, Miliauskaite A, Arweiler N, Brecx M. Treatment of intrabony defects with enamel matrix proteins or bioresorbable membranes. A four year follow up split-mouth study. J Periodontol 2001;72: 1695-1701.
45. Sculean A, Donos N, Schwarz F, Becker J, Brecx M, Arweiler NB. Five year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2004; 31:545-549.
46. Cortellini P, Tonetti MS. Long-term tooth survival following regenerative treatment of intrabony defects. J Periodontol 2004;75:672-678.
47. Eickholz P, Krigar DM, Pretzl B, Steinbrenner H, Dörfer C, Kim TS. Guided tissue regeneration with bioabsorbable barriers. II. Long-term results in infrabony defects. J Periodontol 2004;75:957-965.
48. Stavropoulos A, Karring T. Long-term stability of periodontal conditions achieved following guided tissue regeneration with bioresorbable membranes: Case series results after 6-7 years. J Clin Periodontol 2004; 31:939-944.
49. Zetterström O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704.
50. Parodi R, Santarelli GAE, Gasparetto BEE. Treatment of intrabony defects with Emdogain: Results at 36 months. Int J Periodontics Restorative Dent 2004;24: 57-63.
51. Glise JM, Blanc A, Monnet-Corti VM, Borghetti A. Results at 3 years of treatment of intrabony defects with enamel matrix proteins (in French). J Parodontol Implantol Orale 2005;23:189-196.
52. Sculean A, Chiantella GC, Miliauskaite A, Brecx M, Arweiler NB. Four-year results following treatment with an enamel matrix protein derivative: A report of 46 cases. Int J Periodontics Restorative Dent 2003; 23:345-351.
53. Heden G, Wennström JL. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 2006;77:295-301.
54. Rasperini G, Silvestri M, Ricci G. Long-term clinical observation of treatment of infrabony defects with enamel matrix derivative (Emdogain): Surgical reentry. Int J Periodontics Restorative Dent 2005;25:121-127.
55. Löe H. The Gingival Index, the Plaque Index and the Retention Index system. J Periodontol 1967;38:610-616.
56. Blomlöf JPS, Blomlöf LB, Lindskog SF. Smear removal and collagen exposure after non-surgical root planing followed by etching with EDTA gel preparation. J Periodontol 1996;67:841-845.
57. van Winkelhoff AJ, Rodenburg JP, Goené RJ, Abbas F, Winkel EG, de Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989;16:128-131.
58. Tonetti MS, Pini Prato G, Cortellini P. Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 1996;23:548-556.
59. Ramfjord S, Caffesse R, Morrison E, et al. 4 modalities of periodontal treatment compared over 5 years. J Clin Periodontol 1987;14:445-452.
60. Kaldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK. Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. J Periodontol 1996;67:93-102.
61. Gunsolley JC, Elswick RK, Davenport JM. Equivalence and superiority testing in regeneration clinical trials. J Periodontol 1998;69:521-527.
62. Polson AM, Heijl LC. Osseous repair in infrabony periodontal defects. J Clin Periodontol 1978;5: 13-23.
63. Nowzari H, Matian F, Slots J. Periodontal pathogens on polytetrafluoroethylene membrane for guided tissue regeneration inhibit healing. J Clin Periodontol 1995;22:469-474.
64. Cortellini P, Tonetti MS. Clinical performance of a regenerative strategy for intrabony defects: Scientific evidence and clinical experience. J Periodontol 2005; 76:341-350.